Received: 1 November 2021
Accepted: 28 December 2021
First Online: 27 January 2022
: As a case report, the Human Research Protections Program at the University of California San Diego has confirmed that no ethical approval is required. This report does not include any identifying information of the patient.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: EG has received consulting fees from Novo Nordisk, Currax Pharmaceuticals, and Gelesis, Inc. He has also received research support from the Obesity Treatment Foundation (Grant No OTF001) and Litwin IBD Pioneers Program, Crohn’s and Colitis Foundation.